Cutaneous Surgery Outcomes in Patients on Epidermal Growth Factor Receptor Inhibitors

被引：0
|
作者：
Robinson, Michelle A. [1 ]
Patel, Anisha B. [2 ,3 ]
Wilmas, Kelly M. [2 ]
Thomas, Valencia [3 ]
Heberton, Meghan [3 ]
机构：
[1] John P & Katherine G McGovern Med Sch, Houston, TX 77030 USA
[2] John P & Katherine G McGovern Med Sch, Dept Dermatol, Houston, TX USA
[3] Univ Texas MD Anderson Canc Ctr, Dept Dermatol, Houston, TX 77030 USA
来源：
DERMATOLOGIC SURGERY | 2021年 / 47卷 / 11期
关键词：
D O I：
10.1097/DSS.0000000000003214
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
[No abstract available]
引用
收藏
页码：1519 / 1521
页数：3
相关论文
共 50 条
  • [1] Cutaneous Surgery Outcomes in Patients on Vascular Endothelial Growth Factor Receptor Inhibitors
    Friske, Sarah
    Verma, Kritin K.
    Farooq, Sahira
    Nguyen, Quoc-Bao
    Patel, Anisha B.
    DERMATOLOGIC SURGERY, 2025, 51 (03) : 337 - 339
  • [2] Cutaneous Reactions to Epidermal Growth Factor Receptor Inhibitors
    Pomerantz, Rebecca G.
    Mirvish, Ezra D.
    Geskin, Larisa J.
    JOURNAL OF DRUGS IN DERMATOLOGY, 2010, 9 (10) : 1229 - 1234
  • [3] Adverse cutaneous reactions to epidermal growth factor receptor inhibitors - a study of 14 patients
    Santiago, Felicidade
    Goncalo, Margarida
    Reis, Jose Pedro
    Figueiredo, Americo
    ANAIS BRASILEIROS DE DERMATOLOGIA, 2011, 86 (03) : 483 - 490
  • [4] Cutaneous toxicities of epidermal growth factor receptor inhibitors: A prospective study in 60 Asian patients
    Chularojanamontri, Leena
    Tuchinda, Papapit
    Likitwattananurak, Chayanee
    Pongparit, Kamolwan
    Rujitharanawongi, Chuda
    Ithimakin, Suthinee
    Kulthanan, Kanokvalai
    ASIAN PACIFIC JOURNAL OF ALLERGY AND IMMUNOLOGY, 2019, 37 (01): : 12 - 18
  • [5] Epidermal Growth Factor Receptor Inhibitors: A Review of Cutaneous Adverse Events and Management
    Chanprapaph, K.
    Vachiramon, V.
    Rattanakaemakorn, P.
    DERMATOLOGY RESEARCH AND PRACTICE, 2014, 2014
  • [6] Anticipating and managing the cutaneous side effects of epidermal growth factor receptor inhibitors
    Sinclair, Rod
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2014, 10 : 11 - 17
  • [7] Nursing Management of Cutaneous Toxicities From Epidermal Growth Factor Receptor Inhibitors
    Wallner, Martin
    Koeck-Hodi, Sabine
    Booze, Shaina
    White, Kathryn J.
    Mayer, Hanna
    CLINICAL JOURNAL OF ONCOLOGY NURSING, 2016, 20 (05) : 529 - 536
  • [8] The incidence and management of cutaneous adverse events of the epidermal growth factor receptor inhibitors
    Owczarek, Witold
    Slowinska, Monika
    Lesiak, Aleksandra
    Ciazynska, Magdalena
    Maciag, Aldona
    Paluchowska, Elwira
    Marek-Jozefowicz, Luiza
    Czajkowski, Rafal
    POSTEPY DERMATOLOGII I ALERGOLOGII, 2017, 34 (05): : 418 - 428
  • [9] Cutaneous and biophysical changes among patients receiving treatment with epidermal growth factor receptor inhibitors (EGFRI)
    Chottawornsak, Natcha
    Kantikosum, Kornphaka
    Chongpison, Yuda
    Parinyanitikul, Napa
    Rerknimitr, Pawinee
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : AB143 - AB143
  • [10] Quality of Life Impact in Patients with Cutaneous Toxicities Caused by Epidermal Growth Factor Receptor Inhibitors and Immunotherapy
    Mannino, Maria
    Sollena, Pietro
    Di Stefani, Alessandro
    Rossi, Ernesto
    D'Argento, Ettore
    Schinzari, Giovanni
    Tortora, Giampaolo
    Peris, Ketty
    DERMATOLOGY, 2024, 240 (04) : 523 - 530
12345